Tokio X'press | Tokio X'press - Part 1699

Opivibo, the first cancer immunotherapy drug in China, approved by the Chinese National Drug Administration and Supervision Agency for indications of treatment non-small cell lung cancer with history

Monday June 18th, 2018By Tokio X'press Cancer ONO

ABB and Kawasaki create world’s first common interface for collaborative robots

Thursday June 21st, 2018By Tokio X'press ROBOT, precision khi

Number of foreign visitors to Japan announced estimates for May 2018 16.6% increase from the same month of the previous year 2,675 thousand people

Thursday June 21st, 2018By Tokio X'press Travel & Tourism jnto

World’s Most Innovative Companies – 2018 (Forbes)

Thursday June 21st, 2018By Tokio X'press census, Rating, Company World's Most Innovative Companies

SIPRI: Nuclear weapons still being developed

Monday June 18th, 2018By Tokio X'press weapon, SIPRI SIPRI: Nuclear weapons still being developed